Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Pancreatic Cancer (PDAC) v Pancreatic Neuroendocrine Cancer (PNEN)
Pancreatic Cancer (PDAC) v Pancreatic Neuroendocrine Cancer (PNEN) “The difference isn’t pedantic it’s potentially life-changing”. A common issue in raising awareness of Neuroendocrine Cancer across the media and, indeed, in cancer data reporting itself, is that the...
INCA Global NET Patient Advocate Summit 2021
The INCA Global NET Patient Advocate Summit 2021 will take place today and tomorrow. The Global NET Patient Advocate Summit is a platform for members of INCA, other NET patient advocacy group leaders and advocates and NET medical experts to meet and share ideas to...
What is Primary Neuroendocrine Cancer?
What is Primary Neuroendocrine Cancer? Click here for our free-to-download What is Primary Neuroendocrine information factsheet. This factsheet contains comprehensive information and are aimed at patients, health professionals and anyone wanting to get a better...